Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: Methotrexate Versus Apremilast for Pruritus in Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing methotrexate to apremilast for pruritus in psoriasis is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apremilast (apremilast)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Zarmeen Khawar | Conditions: Psoriasis, Pruritus | Phase 4 | Status: NOT_YET_RECRUITING